Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
No Image Available

Dimethylpolysilonon Tablets 250mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 250mg

Reference Brands:

Category: Gastrointestinal Drugs

Dimethyl polysiloxane is a silicone derivative which is used in symptomatic treatment of postprandial and postoperative flatulence and abdominal distension.It acts as defoaming agent and eliminates gases from GI tract. It is used in combination with antacids, antispasmodics and digestants. 1. Flatulent dyspepsia 2. Postoperative distension

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: -

Dimethylpolysilonon Tablets — third party manufacturing & bulk supply

Dimethylpolysilonon Tablets 250mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Indicative minimum order quantity

Dimethylpolysilonon Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Dimethylpolysilonon Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Dimethylpolysilonon Tablets →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Dimethylpolysilonon Tablets is listed as Tablets in 250mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Dimethylpolysilonon Tablets is catalogued under Gastrointestinal Drugs on PharmaTradz. Related products within the same category are listed at the foot of this page.

Submit an RFQ stating your destination market, required quantity and whether you need stock supply, third party manufacturing or dossier licensing. Matched suppliers respond with pricing, MOQ and lead times.

Related Products

Bismuth Subsalicylate

Strength:
262 mg, 525 mg

Form: Oral suspension / Tablet

Reference Brands: Pepto-Bismol (USA/LATAM),

View Details
Plecanatide

Strength:
3 mg

Form: Tablets

Reference Brands: Trulance (USA)

View Details
Naldemedine

Strength:
0.2 mg

Form: Tablets

Reference Brands: Symproic (USA/EU)

View Details
Resmetirom

Strength:
80 mg ,100 mg

Form: Tablets

Reference Brands: Rezdiffra (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.